MJMark A. Jutila

Mark A. Jutila

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mark A. Jutila has a total of 62 co-authors. Here are the top co-authors by number of shared publications:

  • Jodi F. Hedges

    Veterinary Molecular Biology, Montana State University, Molecular Bioscience Building, 960 Technology Blvd., Bozeman, MT 59718, USA

    5 shared publications
  • Jeff Holderness

    Department of Immunology and Infectious Diseases, Montana State University, Bozeman, Montana, United States of America

    4 shared publications
  • Mark T. Quinn

    Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA

    4 shared publications
  • Andrew G. Ramstead

    Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, United States

    2 shared publications
  • Andrew G. Ramstead

    Department of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA

    2 shared publications
  • Brett Freedman

    Department of Immunology and Infectious Diseases, Montana State University, Bozeman, Montana, United States of America

    2 shared publications

Latest Publications

  • Roles of Toll-Like Receptor 2 (TLR2), TLR4, and MyD88 during Pulmonary Coxiella burnetii Infection

    by Andrew G. Ramstead, Amanda Robison, Anne Blackwell, Maria Jerome, Brett Freedman, Kirk J. Lubick, Jodi F. Hedges, Mark A. Jutila

    Coxiella burnetii, the causative agent of Q fever, is an obligate intracellular primarily pulmonary bacterial pathogen. Though much is known about adaptive immune responses against this bacterium, our understanding of innate immune responses against C. burnetii are not well defined, particularly within the target tissue for infection - the lung. Previous studies examined the roles of the innate immune system receptors, TLR2 and TLR4, in peripheral infection models and described minimal phenotypes in specific gene deletion animals compared to their wildtype controls. Here, we assessed the roles for TLR2, TLR4, and MyD88 in pulmonary C. burnetii infection and compared responses to those that occurred in TLR2 and TLR4 deficient animals following peripheral infection. As observed previously, neither TLR2 nor TLR4 were needed for limiting bacterial growth after peripheral infection. In contrast, TLR2 and to a lesser extent TLR4 limited growth (or dissemination) of the bacterium in the lung and spleen after pulmonary infection. TLR2, TLR4, or MyD88 were not required for the general inflammatory response in the lungs after pulmonary infection. However, MyD88 signaling was important for infection-induced morbidity. Finally, TLR2 expression on hematopoietic cells was most important for limiting bacterial growth in the lung. These results expand on our knowledge of the roles for TLR2 and TLR4 in C. burnetii infection and suggest varying roles for these receptors that are dictated by the site of infection.


  • Open Access

    Aging influences the response of T cells to stimulation by the ellagitannin, oenothein B

    by Andrew G. Ramstead, Igor A. Schepetkin, Kimberly Todd, James Loeffelholz, James G. Berardinelli, Mark T. Quinn, Mark A. Jutila


  • Open Access

    Immunomodulatory activity of polysaccharides isolated from Clerodendrum splendens: Beneficial effects in experimental autoimmune encephalomyelitis

    by Koffi Kouakou, Igor A Schepetkin, SangMu Jun, Liliya N Kirpotina, Ahoua Yapi, Daria S Khramova, David W Pascual, Yury S Ovodov, Mark A Jutila, Mark T Quinn

    Background: Extracts of leaves fromClerodendrumhave been used for centuries to treat a variety of medicinal problems in tropical Africa. However, little is known about the high-molecular weight active components conferring therapeutic properties to these extracts.Methods: Polysaccharides from the leaves ofClerodendrum splendenswere extracted and fractionated by ion exchange and size-exclusion chromatography. Molecular weight determination, sugar analysis, degree of methyl esterification, and other chemical characterization of the fractions were performed. Immunomodulatory activity of the fractions was evaluated by determining their ability to induce monocyte/macrophage nitric oxide (NO), cytokine production, and mitogen-activated protein kinase (MAPK) phosphorylation. Experimental autoimmune encephalomyelitis (EAE) was induced in C57BL/6 mice, and severity of EAE was monitored in mice treated with intraperitoneal (i.p.) injections of the most active polysaccharide fraction. Lymph nodes (LN) and spleen were harvested, and levels of cytokines in supernatants from LN cells and splenocytes challenged with myelin oligodendrocyte glycoprotein peptide were determined.Results: Fractions containing type II arabinogalactan had potent immunomodulatory activity. Specifically, the high-molecular weight sub-fractionCSP-AU1(average of 38.5 kDa) induced NO and cytokine [interleukin (IL)-1α, -1β, -6, -10, tumor necrosis factor (TNF; designated previously as TNF-α), and granulocyte macrophage-colony stimulating factor (GM-CSF)] production by human peripheral blood mononuclear cells (PBMCs) and monocyte/macrophages.CSP-AU1-induced secretion of TNF was prevented by Toll-like receptor 4 (TLR4) antagonist LPS-RS, indicating a role for TLR4 signaling. Treatment withCSP-AU1also induced phosphorylation of a number of MAPKs in human PBMC and activated AP-1/NF-κB.In vivotreatment of mice withCSP-AU1andCSP-NU1resulted in increased serum IL-6, IL-10, TNF, monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein (MIP)-1α/CCL3, and MIP-1β/CCL4.CSP-AU1treatment of mice with EAE (50 mg/kg,i.p., daily, 13 days) resulted in significantly reduced disease severity in this experimental model of multiple sclerosis. Levels of IL-13, TNF, interferon (IFN)-γ, IL-17, and GM-CSF were also significantly decreased, whereas transforming growth factor (TGF)-β was increased in LN cells fromCSP-AU1-treated EAE mice.Conclusions: PolysaccharideCSP-AU1is a potent natural innate immunomodulator with a broad spectrum of agonist activityin vitroand immunosupressive properties after chronic administrationin vivo.


  • Comparative Biology of γδ T Cell Function in Humans, Mice, and Domestic Animals

    by Jeff Holderness, Jodi F. Hedges, Andrew Ramstead, Mark A. Jutila

    γδ T cells are a functionally heterogeneous population and contribute to many early immune responses. The majority of their activity is described in humans and mice, but the immune systems of all jawed vertebrates include the γδ T cell lineage. Although some aspects of γδ T cells vary between species, critical roles in early immune responses are often conserved. Common features of γδ T cells include innate receptor expression, antigen presentation, cytotoxicity, and cytokine production. Herein we compare studies describing these conserved γδ T cell functions and other, potentially unique, functions. γδ T cells are well documented for their potential immunotherapeutic properties; however, these proposed therapies are often focused on human diseases and the mouse models thereof. This review consolidates some of these studies with those in other animals to provide a consensus for the current understanding of γδ T cell function across species.


  • Complex Role of γδ T-Cell-Derived Cytokines and Growth Factors in Cancer

    by Andrew G. Ramstead, Mark A. Jutila

    γδ T cells are innate lymphocytes that recognize and kill a range of tumor cells and are currently being explored as a target for tumor immunotherapy. However, γδ T cells play a complex role in cancer and can promote, as well as inhibit, tumor growth. In addition to tumor cell killing, γδ T cells express a number of cytokines and other soluble factors in response to tumors. Soluble factors expressed by γδ T cells in these settings include interferon-γ, tumor necrosis factor-α, interleukin (IL)-4, IL-10, transforming growth factor-β, IL-17, and a number of growth factors. These factors have differing and sometimes opposing effects on antitumor immunity and tumor angiogenesis, and likely contribute to the complex role of these cells in cancer. Here, we review studies in both mice and humans that examine differential cytokine secretion by γδ T cells in response to tumors and tumor immunotherapy, and discuss the influence of these γδ T-cell-derived factors on tumor growth.


  • Open Access

    Oenothein B, a Cyclic Dimeric Ellagitannin Isolated from Epilobium angustifolium, Enhances IFNγ Production by Lymphocytes

    by Andrew G Ramstead, Igor A Schepetkin, Mark T Quinn, Mark A Jutila

    Oenothein B is a polyphenol isolated from Epilobium angustifolium and other plant sources, which has been reported to exhibit immunomodulatory properties. Oenothein B is known to activate myeloid cells and induce the production of IL-1 and other cytokines. However, its effects on lymphocytes are unknown. In this report, we show that oenothein B stimulated innate lymphocytes, including bovine and human γδ T cells and NK cells, resulting in either increased CD25 and/or CD69 expression. We also demonstrate that oenothein B enhanced the production of interferon-γ (IFNγ) by bovine and human NK cells alone and in combination with interleukin-18 (IL-18), a response not observed with other commonly studied polyphenols. Furthermore, we demonstrate that oenothein B enhanced the production of IFNγ by human T cells. Since IFNγ contributes to antitumor, antibacterial, and antiviral cell responses, these data suggest an additional mechanism that could account, at least in part, for the immune enhancing properties of oenothein B.


  • Open Access

    Polysaccharides Isolated from Açaí Fruit Induce Innate Immune Responses

    by Jeff Holderness, Igor A Schepetkin, Brett Freedman, Liliya N Kirpotina, Mark T Quinn, Jodi F Hedges, Mark A Jutila

    The Açaí (Acai) fruit is a popular nutritional supplement that purportedly enhances immune system function. These anecdotal claims are supported by limited studies describing immune responses to the Acai polyphenol fraction. Previously, we characterized γδ T cell responses to both polyphenol and polysaccharide fractions from several plant-derived nutritional supplements. Similar polyphenol and polysaccharide fractions are found in Acai fruit. Thus, we hypothesized that one or both of these fractions could activate γδ T cells. Contrary to previous reports, we did not identify agonist activity in the polyphenol fraction; however, the Acai polysaccharide fraction induced robust γδ T cell stimulatory activity in human, mouse, and bovine PBMC cultures. To characterize the immune response to Acai polysaccharides, we fractionated the crude polysaccharide preparation and tested these fractions for activity in human PBMC cultures. The largest Acai polysaccharides were the most active in vitro as indicated by activation of myeloid and γδ T cells. When delivered in vivo, Acai polysaccharide induced myeloid cell recruitment and IL-12 production. These results define innate immune responses induced by the polysaccharide component of Acai and have implications for the treatment of asthma and infectious disease.


  • Open Access

    Contribution of transcript stability to a conserved procyanidin-induced cytokine response in γδ T cells

    by K F Daughenbaugh, J Holderness, J C Graff, J F Hedges, B Freedman, J W Graff, M A Jutila

    γδ T cells function in innate and adaptive immunity and are primed for secondary responses by procyanidin components of unripe apple peel (APP). In this study, we investigate the effects of APP and purified procyanidins on γδ T-cell gene expression. A microarray analysis was performed on bovine γδ T cells treated with APP; increases in transcripts encoding granulocyte-monocyte colony stimulating factor (GM-CSF), IL-8 and IL-17, but not markers of TCR stimulation such as IFNγ, were observed. Key responses were confirmed in human, mouse and bovine cells by reverse transcription-PCR and/or ELISA, indicating a conserved response to procyanidins. In vivo relevance of the cytokine response was shown in mice following intraperitoneal injection of APP, which induced production of CXCL1/KC and resulted in neutrophil influx to the blood and peritoneum. In the human T-cell line, MOLT-14, GM-CSF and IL-8 transcripts were increased and stabilized in cells treated with crude APP or purified procyanidins. The ERK1/2 MAPK pathway was activated in APP-treated cells, and necessary for transcript stabilization. Our data describe a unique γδ T-cell inflammatory response during procyanidin treatment and suggest that transcript stability mechanisms could account, at least in part, for the priming phenotype.


  • Antigen-independent priming: a transitional response of bovine γδ T-cells to infection

    by Mark A. Jutila, Jeff Holderness, Jill C. Graff, Jodi F. Hedges

    Analysis of global gene expression in immune cells has provided unique insights into immune system function and response to infection. Recently, we applied microarray and serial analysis of gene expression (SAGE) techniques to the study of γδ T-cell function in humans and cattle. The intent of this review is to summarize the knowledge gained since our original comprehensive studies of bovine γδ T-cell subsets. More recently, we have characterized the effects of mucosal infection or treatment with microbial products or mitogens on gene expression patterns in sorted γδ and αβ T-cells. These studies provided new insights into the function of bovine γδ T-cells and led to a model in which response to pathogen-associated molecular patterns (PAMPs) induces ‘priming’ of γδ T-cells, resulting in more robust responses to downstream cytokine and/or antigen signals. PAMP primed γδ T-cells are defined by up-regulation of a select number of cytokines, including MIP1α and MIP1β, and by antigens such as surface IL2 receptor α (IL-2Rα) and CD69, in the absence of a prototypic marker for an activated γδ T-cell, IFN-γ. Furthermore, PAMP primed γδ T-cells are more capable of proliferation in response to IL-2 or IL-15 in the absence of antigen. PAMPs such as endotoxin, peptidoglycan and β-glucan are effective γδ T-cell priming agents, but the most potent antigen-independent priming agonists defined to date are condensed oligomeric tannins produced by some plants.


  • Response of γδ T Cells to Plant-Derived Tannins

    by Jeff Holderness, Jodi F. Hedges, Katie Daughenbaugh, Emily Kimmel, Jill Graff, Brett Freedman, Mark A. Jutila

    Many pharmaceutical drugs arc isolated from plants used in traditional medicines, and new plant-derived pharmaceutical drugs continue to be identified. Relevant to this review, different plant-derived agonists for γδ T cells are described that impart effector functions upon distinct subsets of these cells. Recently, plant tannins have been defined as one class of γδ T cell agonist and appear to preferentially activate the mucosal population. Mucosal γδ T cells function to modulate tissue immune responses and induce epithelium repair. Select tannins, isolated from apple peel, rapidly induce immune gene transcription in γδ T cells, leading to cytokinc production and increased responsiveness to secondary signals. Activity of these tannin preparations tracks to the procyanidin fraction, with the procyanidin trimer (C1) having the most robust activity defined to date. The response to the procyanidins is evolutionarily conserved in that responses are seen with human, bovine, and murine γδ T cells, although human cells show less selectivity. Procyanidin-induced responses described in this review likely account for the expansion of mucosal γδ T cells seen in mice and rats fed soluble extracts of tannins. Use of procyanidins to activate γδ T cells may represent a novel approach for the treatment of tissue damage and autoimmune diseases.